BE883495A - Medicament hypolipemiqude a base de carnitine - Google Patents

Medicament hypolipemiqude a base de carnitine

Info

Publication number
BE883495A
BE883495A BE2/58580A BE2058580A BE883495A BE 883495 A BE883495 A BE 883495A BE 2/58580 A BE2/58580 A BE 2/58580A BE 2058580 A BE2058580 A BE 2058580A BE 883495 A BE883495 A BE 883495A
Authority
BE
Belgium
Prior art keywords
hypolipemic
carnitine
product based
medicinal product
medicinal
Prior art date
Application number
BE2/58580A
Other languages
English (en)
Original Assignee
Fresenius Chem Pharm Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fresenius Chem Pharm Ind filed Critical Fresenius Chem Pharm Ind
Publication of BE883495A publication Critical patent/BE883495A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE2/58580A 1979-05-29 1980-05-28 Medicament hypolipemiqude a base de carnitine BE883495A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19792921852 DE2921852A1 (de) 1979-05-29 1979-05-29 Lipide senkendes mittel

Publications (1)

Publication Number Publication Date
BE883495A true BE883495A (fr) 1980-09-15

Family

ID=6071966

Family Applications (1)

Application Number Title Priority Date Filing Date
BE2/58580A BE883495A (fr) 1979-05-29 1980-05-28 Medicament hypolipemiqude a base de carnitine

Country Status (5)

Country Link
BE (1) BE883495A (fr)
CH (1) CH646056A5 (fr)
DE (1) DE2921852A1 (fr)
FR (1) FR2457689A1 (fr)
GB (1) GB2052976A (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1120033B (it) * 1979-10-05 1986-03-19 Sigma Tau Ind Farmaceuti Composizione farmaceutica comprendente-carnitina adatta per l'alimentazione parenterale
EP0059775B1 (fr) * 1980-06-09 1984-09-19 Leopold & Co. Chem. pharm. Fabrik Gesellschaft m.b.H. Solution d'infusion pour la protection du foie et l'amélioration de sa fonction et procédé de préparation
IT1157238B (it) * 1982-10-29 1987-02-11 Sigma Tau Ind Farmaceuti Impiego di 1-carnitina per migliorare i paramenti biochimici e comportamentali dell'eta' senile
JPS6217A (ja) * 1985-02-14 1987-01-06 Chugai Pharmaceut Co Ltd 安定な活性型ビタミンｄ３類製剤
IT1190370B (it) * 1985-06-19 1988-02-16 Zambon Spa Composizione farmaceutica solida per uso orale
SE8701662L (sv) * 1987-04-22 1988-10-23 Gelder Nico M Van Saett och medel foer att behandla neurologiska sjukdomar, exempelvis migraen genom paaverkan av nervcellerna
FR2609393A1 (fr) * 1988-02-23 1988-07-15 Serobiologiques Lab Sa Composition notamment utile comme matiere de base pour la preparation de compositions pharmaceutiques, notamment dermatologiques et/ou cosmetiques comprenant une substance azotee, notamment aminoacides, oligo- ou polypeptides, proteines, et leurs derives, et composition pharmaceutique ou cosmetique ainsi preparee.
IT1255039B (it) * 1992-03-11 1995-10-13 Sigma Tau Ind Farmaceuti Impiego di l-carnitina nel trattamento di pazienti hiv-sieropositivi presentanti deficit di carnitina.
GB9416921D0 (en) * 1994-08-22 1994-10-12 Conway Gitta C A nutritional preparation
DE19735126C1 (de) * 1997-08-13 1999-01-21 Infectopharm Arzneimittel Und Verfahren zur Herstellung einer eine Zinkverbindung enthaltenden oralen Zusammensetzung und deren Verwendung zur Behandlung von Erkältungskrankheiten
IT1305308B1 (it) * 1999-03-26 2001-05-04 Biosint S P A Granulato ad alto contenuto di l-carnitina o alcanoil-l-carnitina,particolarmente adatto alla produzione di compresse per compressione
CN1322860C (zh) * 2004-08-31 2007-06-27 北京正大绿洲医药科技有限公司 左旋肉碱滴丸及其制备方法
US7572832B2 (en) * 2007-03-19 2009-08-11 Biolink Life Sciences, Inc. Non-hygroscopic L-carnitine salts
US11865139B2 (en) 2020-11-12 2024-01-09 Thermolife International, Llc Method of treating migraines and headaches

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3810994A (en) * 1972-06-01 1974-05-14 Ethyl Corp Method and composition for treating obesity
US3968241A (en) * 1972-11-06 1976-07-06 Defelice Stephen L Method of treating cardiac arrhythmias and of improving myocardial contractility and systolic rhythm with carnitive or a pharmaceutically acceptable salt thereof
DE2903558C2 (de) * 1978-02-03 1994-09-01 Sigma Tau Ind Farmaceuti Verwendung von L-Carnitin
IT1156741B (it) * 1978-05-15 1987-02-04 Sigma Tau Ind Farmaceuti Applicazione terapeutica della carnitina e di alcuni derivati acilati della carnitina nell'emodialisi
IT1156769B (it) * 1978-05-25 1987-02-04 Sigma Tau Ind Farmaceuti Applicazione terapeutica della carnitina e di altri acil derivati della carnitina

Also Published As

Publication number Publication date
CH646056A5 (de) 1984-11-15
FR2457689A1 (fr) 1980-12-26
DE2921852A1 (de) 1980-12-11
GB2052976A (en) 1981-02-04

Similar Documents

Publication Publication Date Title
BE854270A (fr) Medicament anti-tumeur a base de compose du type lysolecithine
NL7904013A (nl) Farmaceutische verpakking.
DK153631C (da) Medikamentdispenser
FI800910A (fi) Farmaceutiskt anvaendbara 4-amino-3-kinolinkarboxylsyror och -estrar
BE839632A (fr) Medicament a base de sulfadiazine zincique
SE7709359L (sv) Farmaceutisk doseringsform
BE883495A (fr) Medicament hypolipemiqude a base de carnitine
BE854925A (fr) Acides 12-azaprostanoiques utiles comme medicament
BE844532A (fr) Medicament a base d'un derive du benzothiadiazole
FR2307541A1 (fr) Medicament a base d'un polypeptide
BE854171A (fr) 2-imino-thiazolidines et thiazolines utiles comme medicaments
FR2313075A1 (fr) Medicament a base de l-pyroglutamyl-l-histidyl-l-prolinamide ou ses sels
IT8019430A0 (it) Formulazione farmaceutica a cessione protratta.
IT7950715A0 (it) Composizioni farmaceutiche a basedi ariltrifluotoetanolo
SE7614582L (sv) Tillslutningskapsel for en lekemedelsflaska e d
BE865369A (fr) Medicament a base d'extrait de physarym
IT8149179A0 (it) N-(1-allil-2-pirrolidinil-metil)-2metossi-4-ammino-5-metil-solfammoilbenzammide procedimento per produrla e sua applicazione come medicamento
FR2342067A1 (fr) Medicament a base d'un derive de la quinoleine
BE886309A (fr) Nouveau medicament a base d'aspirine et d'heptaminol
IT8025835A0 (it) Ftalazinolo. composizione farmaceutica a base di
BE876100A (fr) Nouvelles desoxyanthracyclines a activite antitumorale utilisables comme medicament
FR2333507A1 (fr) Medicament a base de substances possedant le squelette de l'eburnane
FR2321280A1 (fr) Medicament a base de o-acyl-2,3-diaryl-3-halogeno-acrylaldoximes
FR2326188A1 (fr) Acyl cyanoguanidines utiles comme medicament
RO83817A2 (fr) Produit medicamenteux a action sedative-hypnogene

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: DR. EDUARD FRESENIUS CHEMISCH-PHARMAZEUTISCHE IND

Effective date: 19880531